Combination therapy metformin/pioglitazone/exenatide improving insulin sensitivity and β-cell function in patients with new-onset T2DM is a rather effective and safe therapeutic option that produces a greater and more lasting reduction in HbA1c. The gene discussed is INS; the disease is type 2 diabetes mellitus.